The estimated Net Worth of Sung Lee is at least $2.67 Million dollars as of 27 March 2024. Mr. Lee owns over 6,008 units of Sangamo Therapeutics Inc stock worth over $84,413 and over the last 5 years he sold SGMO stock worth over $59,419. In addition, he makes $2,530,680 as Chief Financial Officer and Executive Vice President at Sangamo Therapeutics Inc.
Sung has made over 1 trades of the Sangamo Therapeutics Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 6,008 units of SGMO stock worth $59,419 on 27 March 2024.
The largest trade he's ever made was selling 6,008 units of Sangamo Therapeutics Inc stock on 27 March 2024 worth over $59,419. On average, Sung trades about 858 units every 0 days since 2019. As of 27 March 2024 he still owns at least 100,492 units of Sangamo Therapeutics Inc stock.
You can see the complete history of Mr. Lee stock trades at the bottom of the page.
Sung H. Lee serves as Chief Financial Officer, Executive Vice President of the Company. Mr. Lee served in various roles at Gilead Sciences, Inc. since 2005 before joining the Company, most recently as Senior Vice President, Financial Planning & Analysis, or FP&A, and Investor Relations from March 2019 to October 2019. Previously, Mr. Lee served as Vice President of FP&A and Investor Relations from September 2018 to February 2019, Vice President of Investor Relations from June 2016 to August 2018, and Senior Director, Investor Relations from 2013 to May 2016. From 2010 to 2013, Mr. Lee was the Head of Europe FP&A at Gilead and prior to that served as the Head of Research & Development FP&A from 2006-2010. Mr. Lee received a B.A. from University of California, Irvine and an M.B.T. from University of Southern California.
As the Chief Financial Officer and Executive Vice President of Sangamo Therapeutics Inc, the total compensation of Sung Lee at Sangamo Therapeutics Inc is $2,530,680. There are 1 executives at Sangamo Therapeutics Inc getting paid more, with Alexander Macrae having the highest compensation of $3,986,560.
Sung Lee is 49, he's been the Chief Financial Officer and Executive Vice President of Sangamo Therapeutics Inc since 2019. There are 14 older and 4 younger executives at Sangamo Therapeutics Inc. The oldest executive at Sangamo Therapeutics Inc is H. Stewart Parker, 64, who is the Independent Director.
Sung's mailing address filed with the SEC is 350 OYSTER POINT BLVD, , SOUTH SAN FRANCISCO, CA, 94080.
Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp, and Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.
for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: